U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C19H23N3O5.C4H4O4
Molecular Weight 862.8782
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BGC-20-1259 fumarate

SMILES

OC(=O)\C=C\C(O)=O.CN[C@@H](CCOC1=CC=C(C=C1)[N+]([O-])=O)C2=CC=C(OC(=O)N(C)C)C=C2.CN[C@@H](CCOC3=CC=C(C=C3)[N+]([O-])=O)C4=CC=C(OC(=O)N(C)C)C=C4

InChI

InChIKey=JOSUCKKYZJUIPW-SOBORHNCSA-N
InChI=1S/2C19H23N3O5.C4H4O4/c2*1-20-18(12-13-26-16-10-6-15(7-11-16)22(24)25)14-4-8-17(9-5-14)27-19(23)21(2)3;5-3(6)1-2-4(7)8/h2*4-11,18,20H,12-13H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*18-;/m00./s1

HIDE SMILES / InChI

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula C19H23N3O5
Molecular Weight 373.403
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 16:59:03 GMT 2025
Edited
by admin
on Tue Apr 01 16:59:03 GMT 2025
Record UNII
6WJ4EP5PJ5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BGC 20-1259 fumarate
Preferred Name English
BGC-20-1259 fumarate
Code English
RS 1259
Code English
(E)-BUT-2-ENEDIOIC ACID; (4-((1S)-1-(METHYLAMINO)-3-(4-NITROPHENOXY)PROPYL)PHENYL) N,N-DIMETHYLCARBAMATE
Systematic Name English
2.4-((1S)-METHYLAMINO-3-(4-NITROPHENOXY)PROPYLPHENYL N,N-DIMETHYLCARBAMATE (FUMARIC ACID)(1-2)SALT)
Systematic Name English
(4-((3S)-3-(4-(DIMETHYLCARBAMOYLOXY)PHENYL)-3-(METHYLAMINO)PROPOXY)PHENYL)AZINIC ACID FUMARIC ACID
Systematic Name English
RS-1259
Code English
Code System Code Type Description
MANUFACTURER PRODUCT INFORMATION
(4-((3S)-3-(4-(DIMETHYLCARBAMOYLOXY)PHENYL)-3-(METHYLAMINO)PROPOXY)PHENYL)AZINIC ACID FUMARIC ACID
Created by admin on Tue Apr 01 16:59:03 GMT 2025 , Edited by admin on Tue Apr 01 16:59:03 GMT 2025
PRIMARY
FDA UNII
6WJ4EP5PJ5
Created by admin on Tue Apr 01 16:59:03 GMT 2025 , Edited by admin on Tue Apr 01 16:59:03 GMT 2025
PRIMARY
PUBCHEM
6918634
Created by admin on Tue Apr 01 16:59:03 GMT 2025 , Edited by admin on Tue Apr 01 16:59:03 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
The compound was as effective as SERT inhibitors such as fluoxetine and fluvoxamine in a 5-hydroxytryptophan-enhancing test in mice. Spatial memory deficits in the two-platform task of a water maze in aged rats were ameliorated by RS-1259 as well as donepezil. Both RS-1259 and donepezil increased the awake episodes in the daytime electroencephalogram of rats. The efficacy of RS-1259 on the consciousness level, which reflects the whole activity in the brain, was almost the same as that of donepezil. These results suggest that both cholinergic and serotonergic systems are involved in maintaining brain arousal and that a dual inhibitor of AChE and SERT may be useful for the treatment of cognitive disorders associated with reduced brain activity such as in Alzheimer's disease.